A detailed history of Lpl Financial LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Lpl Financial LLC holds 37,791 shares of CDXC stock, worth $207,472. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,791
Previous 37,791 -0.0%
Holding current value
$207,472
Previous $103,000 33.01%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$1.36 - $3.84 $452 - $1,278
-333 Reduced 0.87%
37,791 $131,000
Q4 2023

Feb 14, 2024

BUY
$1.28 - $1.6 $3,987 - $4,984
3,115 Added 8.9%
38,124 $54,000
Q3 2023

Nov 13, 2023

BUY
$1.36 - $1.77 $8,287 - $10,786
6,094 Added 21.08%
35,009 $51,000
Q2 2023

Jul 31, 2023

BUY
$1.31 - $1.79 $13,100 - $17,900
10,000 Added 52.87%
28,915 $45,000
Q1 2023

May 10, 2023

BUY
$1.48 - $2.19 $3,537 - $5,234
2,390 Added 14.46%
18,915 $28,000
Q4 2022

Feb 07, 2023

SELL
$1.25 - $1.94 $412 - $640
-330 Reduced 1.96%
16,525 $27,000
Q2 2022

Aug 12, 2022

BUY
$1.59 - $2.7 $8,649 - $14,688
5,440 Added 47.66%
16,855 $28,000
Q1 2022

May 16, 2022

BUY
$2.02 - $3.92 $23,058 - $44,746
11,415 New
11,415 $28,000
Q4 2019

Feb 14, 2020

SELL
$2.83 - $4.61 $32,063 - $52,231
-11,330 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$3.83 - $4.72 $43,393 - $53,477
11,330 New
11,330 $45,000
Q1 2019

May 08, 2019

SELL
$3.2 - $4.19 $39,148 - $51,260
-12,234 Closed
0 $0
Q4 2018

Feb 07, 2019

SELL
$2.8 - $4.22 $10,920 - $16,458
-3,900 Reduced 24.17%
12,234 $42,000
Q3 2018

Nov 14, 2018

BUY
$3.5 - $4.91 $815 - $1,144
233 Added 1.47%
16,134 $69,000
Q2 2018

Aug 14, 2018

BUY
$3.22 - $4.43 $3,220 - $4,430
1,000 Added 6.71%
15,901 $59,000
Q1 2018

May 15, 2018

BUY
$4.05 - $6.46 $12,421 - $19,812
3,067 Added 25.92%
14,901 $63,000
Q4 2017

Feb 14, 2018

BUY
$3.88 - $6.96 $45,915 - $82,364
11,834
11,834 $70,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $375M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.